About Lucrose Pharma
Lucrose Pharma is a Healthcare company. Pharmaceutical manufacturing and diagnostic services in India. The company has 186 employees. Its Indian entity Lucrose Pharma Private Limited reported revenue of ₹22.61 Cr. Lucrose Pharma offers products and services including RABLUC Tablets and GROWLUC-JR Syrups. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Diagnostic Services.
Company details
Lucrose Pharma is known for formulating and developing affordable medicines that address urgent medical needs, with operations beginning in 2016 and full integration achieved in 2017. A range of products, including tablets, capsules, syrups, and suspensions, is offered alongside diagnostic services such as molecular testing and oncology. Offices are established in Greater Noida, Meerut, and Lucknow, where efforts are directed towards commercializing accessible healthcare solutions. The companys focus is maintained on community health support through these initiatives.
- Employees 186
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Lucrose Pharma Private Limited
- Date of Incorporation 14 Jul, 2016
- Jurisdiction Meerut, Uttar Pradesh, India
- Indian entity revenue₹22.61 Cr
FY 2025 · +10% YoY
- Indian entity net profit₹43.4 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹88.8 Lakh
FY 2025 · 4% margin
- Employee Count186
Associated legal entities of Lucrose Pharma
Lucrose Pharma operates through Lucrose Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lucrose Pharma Private Limited CIN U74999UP2016PTC084888 | Active | 14 Jul 2016 | Meerut, Uttar Pradesh | ₹22.6 Cr | 186 | 5 | View details |
Products & Services of Lucrose Pharma
Lucrose Pharma offers a comprehensive portfolio of products and services, including RABLUC Tablets and GROWLUC-JR Syrups.
RABLUC Tablets are manufactured with Rabeprazole Sodium and Levosulpiride for medical purposes.
GROWLUC-JR Syrups are formulated with ingredients like Cyproheptadine HCl and various vitamins for health applications.
Board of directors of Lucrose Pharma Private Limited (Lucrose Pharma)
Lucrose Pharma Private Limited is the primary company behind Lucrose Pharma. The board of Lucrose Pharma Private Limited currently have 5 directors; the longest-serving is Dinesh Kumar, appointed in 2016. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Kumar DIN 07519621 | Director | 14 Jul 2016 | 10 yrs 3 mo | Lucrose Pharma Private Limited |
| Gajendra Singh DIN 02079524 | Director | 14 Jul 2016 | 10 yrs 3 mo | Lucrose Pharma Private Limited |
| Anita Singh DIN 03369261 | Director | 08 Aug 2021 | 5 yrs 2 mo | Lucrose Pharma Private Limited |
| Amit Verma DIN 08474655 | Director | 05 Oct 2021 | 5 yrs | Lucrose Pharma Private Limited |
| Pawan Pandey DIN 06505418 | Director | 10 May 2025 | 1 yr 5 mo | Lucrose Pharma Private Limited |
Financials of Lucrose Pharma
Figures of Lucrose Pharma Private Limited, the primary company behind Lucrose Pharma, for FY 2025. Revenue was ₹22.61 Cr (+10% year on year). Net profit was ₹43.4 Lakh (2% margin). EBITDA was ₹88.8 Lakh (4% margin). Revenue has grown at a compounded annual rate of +15% over three years and +23% over five years.
- ₹22.61 CrRevenue · FY 2025 · +10% YoY
- ₹43.4 LakhNet profit · 2% margin
- ₹88.8 LakhEBITDA · 4% margin
- ₹50 LakhPaid-up capital
- 186Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lucrose Pharma Private Limited are on its company page.
Detailed financial statements for Lucrose Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lucrose Pharma
Lucrose Pharma has 186 employees.
The primary company behind Lucrose Pharma, Lucrose Pharma Private Limited, reported revenue of ₹22.61 Cr for FY 2025, up 10% year on year.
Lucrose Pharma is known for formulating and developing affordable medicines that address urgent medical needs, with operations beginning in 2016 and full integration achieved in 2017. A range of products, including tablets, capsules, syrups, and suspensions, is offered alongside diagnostic services such as molecular testing and oncology. Offices are established in Greater Noida, Meerut, and Lucknow, where efforts are directed towards commercializing accessible healthcare solutions. The companys focus is maintained on community health support through these initiatives.
Lucrose Pharma offers RABLUC Tablets and GROWLUC-JR Syrups.
Lucrose Pharma operates through Lucrose Pharma Private Limited.
The legal entities of Lucrose Pharma currently have 5 directors, including Dinesh Kumar, Anita Singh, Gajendra Singh and others.